G 3
Pill imprint G 3 has been identified as Alprazolam extended-release 3 mg.
Alprazolam is used in the treatment of anxiety; depression; panic disorder; tinnitus; dysautonomia and belongs to the drug class benzodiazepines. There is positive evidence of human fetal risk during pregnancy.
Alprazolam 3 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Alprazolam extended-release Images
- Imprint:
-
G
3 - Strength:
- 3 mg
- Color:
- Green
- Size:
- 10.00 mm
- Shape:
- Three-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose
magnesium stearate
silicon dioxide
hypromellose
D&C Yellow No. 10
FD&C Blue No. 2
- Drug Class:
- Benzodiazepines
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Greenstone Limited
- National Drug Code (NDC):
- 59762-0068
| NDC Code | Manufacturer / Repackager |
|---|---|
| 35356-0505 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More Alprazolam Extended-Release resources
- Alprazolam
- Alprazolam (Wolters Kluwer)
- Alprazolam Extended-Release Tablets (Wolters Kluwer)
- Alprazolam Orally Disintegrating Tablets (Wolters Kluwer)
- Alprazolam Solution (Wolters Kluwer)
- alprazolam (Cerner Multum)
- Alti-Alprazolam (Micromedex) - Includes Dosage Information
- Gabazolamine-0.5 (Micromedex) - Includes Dosage Information
- alprazolam (Micromedex) - Includes Dosage Information
- Alprazolam (AHFS DI)
- Alprazolam (FDA)
- Alprazolam Extended Release (FDA)
- Alprazolam ODT (FDA)
- Alprazolam XR (FDA)
- Alprazolam (Wolters Kluwer)


